Medicare AdvantagePrior AuthMedium impact
Tasmar® (tolcapone) (Revised)
Humana·Neurology, Family Medicine, Internal Medicine +1 more·Medicare Advantage
Effective date
Jan 1, 2024
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage now requires prior authorization for Tasmar (tolcapone) prescriptions for Parkinson's disease patients. Five specific criteria must be met including current levodopa/carbidopa use, failed trial of entacapone plus one other adjunct therapy, and baseline liver function tests.
Action Required
Immediately: Billing team must verify prior authorization is obtained before dispensing Tasmar (tolcapone) for Medicare Advantage patients. Providers must document all five criteria: Parkinson's diagnosis, current levodopa/carbidopa use with symptom fluctuations, failed trial of entacapone plus one other adjunct therapy, combination use with levodopa/carbidopa, and baseline liver function tests. Claims will be denied without proper prior authorization.